I wonder if the cost benefit analysis would show that this is still the best policy - I.e. are more people dying because of overdose of acetaminophen than would have from “behind the counter” + controlled acquisition of codeine products.
I would also imagine that the compliance / nationwide tracking is now much easier than when the legislation was initially conceived.
I wonder if the cost benefit analysis would show that this is still the best policy - I.e. are more people dying because of overdose of acetaminophen than would have from “behind the counter” + controlled acquisition of codeine products.
I would also imagine that the compliance / nationwide tracking is now much easier than when the legislation was initially conceived.